DSCSA T3 Data Standardization and Documentation Practices
The FDA released the draft guidance which provides a significant amount of detail regarding the
standardization of product tracing information, its specific data elements; and recommended
documentation practices trading partners may utilize to satisfy their product tracing requirements. This
guidance supplements the DSCSA Standards for the Interoperable Exchange of Information for Tracing of
Certain Human, Finished, Prescription Drugs: How to Exchange Product Tracing Information guidance
released in November 2014.
Want to read the entire article?
Sign up now to view the document.
Excellis is committed to protecting your privacy and personal information. All information will be kept confidential.